시장보고서
상품코드
1274621

세계의 약물 남용(DOA) 검사 시장 보고서(2023년)

Drugs of Abuse (DOA) Testing Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 약물 남용(DOA) 검사 시장은 2022년 60억 3,000만 달러에서 2023년 66억 5,000만 달러에 달하고, 연평균 10.1% 성장할 것으로 예상됩니다. 러시아-우크라이나 전쟁은 적어도 단기적으로는 코로나19 팬데믹으로 인한 세계 경제 회복의 기회를 방해했습니다. 양국 간의 전쟁은 여러 국가에 대한 경제 제재, 상품 가격 급등, 공급망 혼란으로 이어져 전체 상품 및 서비스 인플레이션을 유발하고 세계 많은 시장에 영향을 미쳤습니다. 약물 남용(DOA) 검사 시장은 2027년까지 연평균 8.9%의 CAGR로 성장하여 93억 5,000만 달러에 달할 것으로 예상됩니다.

북미는 2022년 약물 남용(DOA) 검사 시장에서 가장 규모가 큰 지역이 될 것으로 예상됩니다. 아시아태평양은 예측 기간 동안 가장 빠르게 성장할 것으로 예상됩니다. 약물 남용(DOA) 검사 보고서의 대상 지역은 아시아태평양, 서유럽, 중동 및 북유럽, 북미, 남미, 중동 및 아프리카입니다.

약물 남용 치료에 대한 수요 증가는 향후 약물 오남용(DOA) 검사 시장의 성장을 가속할 것으로 예상됩니다. 약물 남용 또는 약물 남용은 사용자와 타인에게 해를 끼칠 수 있는 양의 물질을 사용하는 것을 말합니다. 약물 검사는 일반적으로 체내에 존재하지 않는 화합물을 식별하는 데 도움을 줍니다. 이 과정은 선별 검사로 시작하여 두 번째 검사에서 물질 또는 물질의 존재를 확인하기 때문에 약물 남용 치료에 대한 수요 증가는 시장 성장을 가속할 것입니다. 예를 들어, 2021년 6월 미국에 본사를 둔 마약통제 및 범죄예방기구인 유엔마약범죄사무소(UNODC)가 '유엔 국제보고서 2021 세계마약보고서'를 통해 발표한 바에 따르면, 2020년 세계 3,600만 명 이상이 약물 사용 장애를 앓고 있으며, 2억 7,500만 명 이상이 이상이 약물을 사용하고 있습니다. 따라서 약물 남용 치료에 대한 수요 증가가 약물 남용(DOA) 검사 시장을 주도하고 있습니다.

목차

제1장 주요 요약

제2장 남용 약물(DOA) 검사 시장 특징

제3장 남용 약물(DOA) 검사 시장 동향과 전략

제4장 남용 약물(DOA) 검사 시장 - 거시경제 시나리오

  • COVID-19가 남용 약물(DOA) 검사 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 남용 약물(DOA) 검사 시장에 미치는 영향
  • 고인플레이션이 남용 약물(DOA) 검사 시장에 미치는 영향

제5장 남용 약물(DOA) 검사 시장 규모와 성장

  • 세계의 남용 약물(DOA) 검사 시장 실적, 2017-2022년
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 남용 약물(DOA) 검사 시장 예측, 2022년부터 2027년, 2032년
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 남용 약물(DOA) 검사 시장 세분화

  • 세계의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 애널라이저
  • 신속 검사 장비
  • 소모품
  • 검사 서비스
  • 세계의 남용 약물(DOA) 검사 시장, 샘플 유형별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 소변
  • 모발
  • 호흡
  • 세계의 남용 약물(DOA) 검사 시장, 용도별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 통증 관리
  • 형사 사법
  • 직장 스크리닝
  • 세계의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 병원
  • 진단 연구소
  • 법의학 연구소
  • 기타 최종사용자

제7장 남용 약물(DOA) 검사 시장 : 지역 및 국가별 분석

  • 세계의 남용 약물(DOA) 검사 시장, 지역별, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 남용 약물(DOA) 검사 시장, 국가별, 실적 및 예측, 2017-2022년, 2022년부터 2027년, 2032년

제8장 아시아태평양의 남용 약물(DOA) 검사 시장

  • 아시아태평양의 남용 약물(DOA) 검사 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 규제, 규제기관, 주요 단체, 과세액, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아시아태평양의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국의 남용 약물(DOA) 검사 시장

  • 중국의 남용 약물(DOA) 검사 시장 개요
  • 중국의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중국의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 남용 약물(DOA) 검사 시장

  • 인도의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 남용 약물(DOA) 검사 시장

  • 일본의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 일본의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주의 남용 약물(DOA) 검사 시장

  • 호주의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 호주의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아의 남용 약물(DOA) 검사 시장

  • 인도네시아의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 남용 약물(DOA) 검사 시장

  • 한국의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 한국의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽의 남용 약물(DOA) 검사 시장

  • 서유럽의 남용 약물(DOA) 검사 시장 개요
  • 서유럽의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국의 남용 약물(DOA) 검사 시장

  • 영국의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 영국의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일의 남용 약물(DOA) 검사 시장

  • 독일의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 독일의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스의 남용 약물(DOA) 검사 시장

  • 프랑스의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽의 남용 약물(DOA) 검사 시장

  • 동유럽의 남용 약물(DOA) 검사 시장 개요
  • 동유럽의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아의 남용 약물(DOA) 검사 시장

  • 러시아의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미의 남용 약물(DOA) 검사 시장

  • 북미의 남용 약물(DOA) 검사 시장 개요
  • 북미의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 북미의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국의 남용 약물(DOA) 검사 시장

  • 미국의 남용 약물(DOA) 검사 시장 개요
  • 미국의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 미국의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미의 남용 약물(DOA) 검사 시장

  • 남미의 남용 약물(DOA) 검사 시장 개요
  • 남미의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 남미의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질의 남용 약물(DOA) 검사 시장

  • 브라질의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동의 남용 약물(DOA) 검사 시장

  • 중동의 남용 약물(DOA) 검사 시장 개요
  • 중동의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 중동의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카의 남용 약물(DOA) 검사 시장

  • 아프리카의 남용 약물(DOA) 검사 시장 개요
  • 아프리카의 남용 약물(DOA) 검사 시장, 제품 및 서비스별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카의 남용 약물(DOA) 검사 시장, 최종사용자별 세분화, 실적 및 예측, 2017-2022, 2022-2027F, 2032F

제27장 남용 약물(DOA) 검사 시장 경쟁 구도와 기업 개요

  • 남용 약물(DOA) 검사 시장 경쟁 구도
  • 남용 약물(DOA) 검사 시장 기업 개요
    • Abbott Laboratories
    • Danaher Corporation
    • Laboratory Corporation of America Holdings
    • Dragerwerk AG &Co. KGaA
    • Quest Diagnostics Inc.

제28장 남용 약물(DOA) 검사 시장의 주요 인수합병(M&A)

제29장 남용 약물(DOA) 검사 시장 전망과 가능성 분석

제30장 부록

LSH 23.05.25

“Drugs of Abuse (DOA) Testing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drugs of abuse (doa) testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
  • 2) By Sample Type: Urine; Hair; Oral Fluid; Breath
  • 3) By Application: Pain Management; Criminal Justice; Workplace Screening
  • 4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
  • Companies Mentioned: Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings; Dragerwerk AG & Co. KGaA; Quest Diagnostics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the drugs of abuse (doa) testing market are Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc., United States Drug Testing Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd, Cordant Health Solutions, Omega Laboratories Inc., Psychemedics Corporation, Zimmer Biomet, Homology Medicines Inc., and bioMerieux Inc.

The global drugs of abuse (DOA) testing market is expected to grow from $6.03 billion in 2022 to $6.65 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%.The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The drugs of abuse (DOA) testing market is expected to reach $9.35 billion in 2027 at a CAGR of 8.9%.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Drug of abuse (DOA) testing refers to the examination of a substance, such as a drug, chemical, or plant product, that is usually treated recreationally. It includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are tested for on a drug panel. The patient's urine, saliva, blood, hair, or sweat are used in this clinical screening procedure.

North America was the largest region in the drugs of abuse(DOA) testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drugs of abuse (DOA) testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products and services for drug of abuse (DOA) testing are analyzers, rapid testing devices, consumables, and laboratory services. An analyzer is a device that automatically measures the chemical concentration of one or more components or another associated physical quantity, continuously or intermittently. There are sample types included such as urine, hair, oral fluid, and breat, and are available in various applications such as pain management, criminal justice, and workplace screening. The end users involves hospitals, diagnostic laboratories, forensic laboratories, and others.

Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in June 2021, according to United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug use disorders, and over 275 million people used drugs in 2020. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.

Technology advancement is a key trend gaining popularity in the drugs of abuse (DOA) testing market. Major companies operating in the drugs of abuse (DOA) testing market are focused on developing new technological solutions to strengthen their position in the market. For instance, in May 2020, a Canada-based technology company created instruments to detect THC in breath for law enforcement. Cannabix Technologies' point-of-care breath testing solutions is used for the detection of 9-tetrahydrocannabinol ("THC"), the psychoactive element in marijuana that contributes to impairment, are at the forefront of industry research and development. The THCBA detects THC in breath using microfluidic sensor technology. The THCBA includes appealing features such as single-stage direct breath capabilities and a one-handed ergonomic design. So far, testing has shown that the device can produce results in less than 5 minutes from the time the sample is eaten.

In June 2020, Medix Biochemica, a Finland-based biotechnology company, acquired Biostride Inc. for an undisclosed amount. With this acquisition, Biostride's array of drug of abuse antibodies and antigens is now available to IVD and drug testing customers worldwide. The acquisition is consistent with Medix's plan to streamline the IVD supply chain and emerge as the industry's top provider of vital raw materials. Biostride Inc., a US-based producer of antibodies and antigens for the IVD industry for drugs of abuse and hormone testing.

The countries covered in the drugs of abuse (DOA) testing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Drugs of Abuse (DOA) Testing Market
  • 4.2. Ukraine-Russia War Impact On Drugs of Abuse (DOA) Testing Market
  • 4.3. Impact Of High Inflation On Drugs of Abuse (DOA) Testing Market

5. Drugs of Abuse (DOA) Testing Market Size And Growth

  • 5.1. Global Drugs of Abuse (DOA) Testing Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Drugs of Abuse (DOA) Testing Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Drugs of Abuse (DOA) Testing Market Segmentation

  • 6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Analyzers
  • Rapid Testing Devices
  • Consumables
  • Laboratory Services
  • 6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Urine
  • Hair
  • Oral Fluid
  • Breath
  • 6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Pain Management
  • Criminal Justice
  • Workplace Screening
  • 6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Other End Users

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

  • 7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

  • 8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

  • 9.1. China Drugs of Abuse (DOA) Testing Market Overview
  • 9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

  • 10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

  • 11.1. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

  • 12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

  • 13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

  • 14.1. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

  • 15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
  • 15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

  • 16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

  • 17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

  • 18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Drugs of Abuse (DOA) Testing Market

  • 19.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
  • 19.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Drugs of Abuse (DOA) Testing Market

  • 20.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Drugs of Abuse (DOA) Testing Market

  • 21.1. North America Drugs of Abuse (DOA) Testing Market Overview
  • 21.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Drugs of Abuse (DOA) Testing Market

  • 22.1. USA Drugs of Abuse (DOA) Testing Market Overview
  • 22.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Drugs of Abuse (DOA) Testing Market

  • 23.1. South America Drugs of Abuse (DOA) Testing Market Overview
  • 23.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Drugs of Abuse (DOA) Testing Market

  • 24.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Drugs of Abuse (DOA) Testing Market

  • 25.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
  • 25.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Drugs of Abuse (DOA) Testing Market

  • 26.1. Africa Drugs of Abuse (DOA) Testing Market Overview
  • 26.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

  • 27.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
  • 27.2. Drugs of Abuse (DOA) Testing Market Company Profiles
    • 27.2.1. Abbott Laboratories
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Danaher Corporation
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Laboratory Corporation of America Holdings
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Dragerwerk AG & Co. KGaA
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Quest Diagnostics Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

29. Drugs of Abuse (DOA) Testing Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제